Structure-based design of the first potent and selective inhibitor of human non-pancreatic secretory phospholipase A2-Reference-Cited by-同舟云学术

Structure-based design of the first potent and selective inhibitor of human non-pancreatic secretory phospholipase A2

Published:1995-06 Issue:6 Volume:2 Page:458-465
ISSN:1545-9993
Container-title:Nature Structural & Molecular Biology
language:en
Short-container-title:Nat Struct Mol Biol

Author:

Schevitz R.W.,Bach N.J.,Carlson D.G.,Chirgadze N.Y.,Clawson D.K.,Dillard R.D.,Draheim S.E.,Hartley L.W.,Jones N.D.,Mihelich E.D.,Olkowski J.L.,Snyder D.W.,Sommers C.,Wery J.-P.

Publisher

Springer Science and Business Media LLC

Subject

Molecular Biology,Structural Biology

Link

http://www.nature.com/articles/nsb0695-458.pdf

Reference31 articles.

1. Circulating phospholipase A2 activity associated with sepsis and septic shock is indistinguishable from that associated with rheumatoid arthritis

2. Structure and Properties of a Human Non-pancreatic Phospholipase A2

3. Role of phospholipases in generating lipid second messengers in signal transduction 1

4. Are Events After Endotoxemia Related to Circulating Phospholipase A2 ?

Cited by 244 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rapid Movement of Palmitoleic Acid from Phosphatidylcholine to Phosphatidylinositol in Activated Human Monocytes;Biomolecules;2024-06-15

2. An update on the pharmacological management of acute respiratory distress syndrome;Expert Opinion on Pharmacotherapy;2024-06-12

3. Interactions of small molecule inhibitors with secreted phospholipase A₂: A review of the structural data;Chemical Biology & Drug Design;2024-01-29

4. Phospholipases A2;Metalloenzymes;2024

5. Structure Activity Relationship and Molecular Docking of Some Quinazolines Bearing Sulfamerazine Moiety as New 3CLpro, cPLA2, sPLA2 Inhibitors;Molecules;2023-08-14